REFRACTORY HEPATOCELLULAR CARCINOMA
Clinical trials for REFRACTORY HEPATOCELLULAR CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new REFRACTORY HEPATOCELLULAR CARCINOMA trials appear
Sign up with your email to follow new studies for REFRACTORY HEPATOCELLULAR CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Personalized immune cells take aim at tough liver cancers
Disease control TerminatedThis early-stage study is testing a new treatment for advanced liver cancer that has come back or stopped responding to standard therapies. Doctors take a patient's own immune cells, modify them in a lab to better recognize and attack cancer cells, and then infuse them back into …
Matched conditions: REFRACTORY HEPATOCELLULAR CARCINOMA
Phase: PHASE1 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
New hope pill tested for kids with tough cancers
Disease control OngoingThis study is testing whether a pill called cabozantinib can help control rare cancers that have come back or stopped responding to other treatments in children and young adults. It includes patients with sarcomas, Wilms tumor, and other rare tumors. The drug aims to slow or stop…
Matched conditions: REFRACTORY HEPATOCELLULAR CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC